Efficacy and safety of proton pump inhibitors and Histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis of randomized trials

ZHANG Hong; YUAN Jian; YU Xiangli; YE lin; YANG Chunmei

PDF(769 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2019, Vol. 30 ›› Issue (6) : 510-512.

Efficacy and safety of proton pump inhibitors and Histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis of randomized trials

ZHANG Hong, YUAN Jian, YU Xiangli, YE lin, YANG Chunmei

Author information +

History +

Abstract

Objective To compare the curative effect and safety of proton pump inhibitors (PPI) and histamine-2-receptor antagonists (H₂RAs) when used to prevent stress ulcer prophylaxis in critically ill patients.Methods Randomized controlled trials (RCTs) of PPI vs H₂RA for stress ulcer prophylaxis in patients in critical condition were retrieved from the Cochrane library, PubMed, Embase, Science Direct,CNKI and CMB databases. Key indexes included gastrointestinal (GI) bleeding, iatrogenic pneumonia, Clostridium difficile infection, mortality and length of stay in the ICU.Results Prophylactic application of PPIs can reduce the risk of clinical gastrointestinal bleeding and upper gastrointestinal bleeding compared with H₂RA.Conclusions PPIs are superior to H₂RAs in preventing GI bleeding without significantly increasing the risk of pneumonia or mortality. However,their impact on Clostridium difficile infections remains uncertain.

Key words

proton pump inhibitor / histamine-2-receptor antagonist / stress ulcer / meta-analysis

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Hong, YUAN Jian, YU Xiangli, YE lin, YANG Chunmei. Efficacy and safety of proton pump inhibitors and Histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis of randomized trials[J]. Medical Journal of the Chinese People Armed Police Forces. 2019, 30(6): 510-512

References

[1] Skillman J J, Silen W. Acute gastroduodenal “stress” ulceration: barrier disruption of varied pathogenesis?[J]. Gastroenterology, 1970, 59(3):478-482.
[2] Fogas J F, Kiss K K.Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients[J]. Intensive Care Medicine, 2015, 41(5):833-845.
[3] Cook D J, Griffith L E, Walter S D, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients[J]. Critical Care, 2001, 5(6):368-375.
[4] Barletta J F, Kanji S, Maclaren R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada[J]. J Criti Care, 2014, 29(6):955-960.
[5] Eastwood G M, Ed L, Rinaldo B, et al. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units[J]. Critical Care & Resuscitation, 2014, 16(3):170-174.
[6] Wee B, Liu C H, Cohen H, et al. IV Famotidine vs. IV Pantoprazole for Stress Ulcer Prevention in the ICU: A Prospective Study[J]. Criti Care Med, 2013, 41(12):765-768.
[7] Bashar F R, Manuchehrian N, Mahmoudabadi M, et al. Effects of Ranitidine and Pantoprazole on Ventilator-Associated Pneumonia: A Randomized Double-Blind Clinical Trial[J]. Tanaffos, 2013, 12(2):16.
[9] Liu B L, Li B, Zhang X, et al. A randomized controlled study comparing omeprazole and cimetidine for the prophylaxis of stress-related upper gastrointestinal bleeding in patients with intracerebral hemorrhage[J]. J Neurosurg, 2013, 34(1):115-120.
[10] Kotlyanskaya A, Cohen H, Luka B,et al. A comparison of lansoprazole disintegrating tablet, lansoprazole suspension or ranitidine for stress ulcer prophylaxis in critically ill patients[J]. Crit Care Med, 2007,35(12):A194.
[11] Phillips, Jeffrey O, Metzler, et al. A Multicenter, Prospective, Randomized Clinical Trial of Continuous Infusion I.V. Ranitidine Vs. Omeprazole Suspension in the Prophylaxis of Stress Ulcers[]. Critical Care Medicine, 1998, 26(1):101A.
[12] Fink M, Karlstadt R G, Maroko R T, et al. Intravenous pantoprazole (IVP) and continuous infusion cimetidine (C) prevent upper gastrointestinal bleeding (UGIB) regardless of APSII score (APACHE II) in high risk intensive care unit (ICU) patients[J]. Gastroenterology, 2003, 124(4):A625-A626.
[13] Somberg L, Jr M J, Fantus R, et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease[J]. J Trauma & Acute Care Surg, 2008, 64(5):1202.
[14] Bhanot R D. Nosocomial Pneumonia In Mechanically Ventilated Patients Receiving Ranitidine, Omeprazole or Sucralfate As Stress Ulcer Prophylaxis[J]. Digestive Diseases and Sciences, 1997, 42(6):1255-1259.
[15] Conrad S A, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients[J]. Critical Care Medicine, 2005, 33(4):760-765.
[16] Azevedo J R, Soares M G, Silva G, et al. Prevention of Sress Ulcer Bleeding in High Risk Patients. Comparison of Three Drugs[J]. Critical Care Medicine, 1999, 27(27):A145.
[17] Hata M, Shiono M, Sekino H, et al. Prospective Randomized Trial for Optimal Prophylactic Treatment of the Upper Gastrointestinal Complications After Open Heart Surgery[J]. Circulation J, 2005, 69(3):331-334.
[18] Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial[J]. Hepatogastroenterology,2004,51(57):757-761.
[19] Pan X, Zhang W, Zhaoshen L I, et al. The Preventive Effects of Rabeprazole on Upper Gastrointestinal Tract Hemorrhage in Patients with Severe Acute Pancr eatitis[J]. Chin J Gastroentero, 2004, 9(1):30-32.
[20] Levy M J, Seelig C B, Robinson N J, et al. Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis[J]. Dig Dis Sci, 1997, 42(6):1255-1259.
[21] Powell H, Morgan M, Li SK, et al. Inhibition of gastric acid secretion in the intensive care unit after coronary artery bypass graft. A pilot control study of intravenous omeprazole by bolus and infusion, ranitidine and placebo[J]. Theor Surg,1993,8(3):125-130.
[22] Risaliti A, Terrosu G, Uzzau A, et al. Intravenous omeprazole vs ranitidine in the prophylaxis of stress ulcers[J]. Acta Chir Ital, 1993,49(4):397-401.
[23] Solouki M, Mehran S, Ashian M, et al. Ventilator-associated pneumonia among ICU patients receiving mechanical ventilation and prophylaxis of gastrointestinal bleeding[J]. Iranian Journal of Clinical Infectious Diseases, 2009, 444(3):177-180.
[24] Lee, Wenjun Z.Comparison of the efficacy of esomeprazole and famotidine against stress ulcers in a neurosurgical intensive care unit[J]. Advances in Digestive Medicine, 2014, 1(2):50-53.
[25] Maclaren R, Reynolds P M, Allen R R. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit[J]. Jama Inter Med, 2014, 174(4):564-574.
[26] Leonard J, Marshall J K, Moayyedi P. Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression[J]. Am J Gastroentero, 2007, 102(9):2047-2056.
[27] Yan H, Peng X, Huang Y, et al. Effects of early enteral arginine supplementation on resuscitation of severe burn patients[J]. Burns, 2007, 33(2):179-184.